by Elena Iemma | Jun 28, 2021 | Featured, Thinking Out Loud -Blog
After a year of virtual meetings, EpiVax is thrilled to announce that we will be resuming our much loved Immunogenicity Seminar series in-person, starting Fall 2021! We have an exciting line-up of dates and speakers and we will announce more as they are confirmed....
by Elena Iemma | Jun 10, 2021 | Featured, Thinking Out Loud -Blog
EpiVax has been busy helping our clients, and the research flywheel is spinning faster than ever. We needed more talented folks to pitch in! So far we’ve brought on six wonderful team members in 2021, with more to come soon! Learn more about our new folks below,...
by Elena Iemma | May 21, 2021 | Events, Featured, Webinars
EpiVax CEO/CSO Annie De Groot and Director of Analysis Frances Terry co-presented “Engineering Better Biologics: Does Nature Know Best?” at the 2021 AAPS NBC conference May 19th 2021. Outline: Background on T cells / Immunogenicity EpiMatrix, JanusMatrix ...
by Elena Iemma | May 18, 2021 | Featured, Thinking Out Loud -Blog
The news from Mali Here in Bamako, life is really not that much different from so many other countries. On the street, the average citizen is still hawking gasoline in glass bottles for 500 CFA, selling sunglasses at traffic stops, or herding goats across the road,...
by Elena Iemma | Apr 27, 2021 | Featured, News
PROVIDENCE, RI, April 27, 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) announces the publication “Tregitopes Improve Asthma by Promoting Highly Suppressive and Antigen-Specific Tregs” in Frontiers in Immunology. This research highlights Tregitopes as a promising...